I take your above points. I can't' ignore how significant the results were. Patients in the same epicentre with same treatment everyone else is getting and all of a sudden 75% off ventilators within 10 days, with 83% survival.
You mentioned there could be some reasons for the trail results. I understand, in this case all patients were on ventilators and 83%???? Also, Silvi Itescu said, big pharmas like Gilead with Remdesivir and Hydroxychloroquine have failed to date.
At the moment, MSB is in front in the home turn and worth the risk.
- Forums
- ASX - By Stock
- Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
I take your above points. I can't' ignore how significant the...
-
- There are more pages in this discussion • 326 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 27197 | $1.11 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.13 | 43578 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 27197 | 1.105 |
8 | 87146 | 1.100 |
2 | 71941 | 1.095 |
2 | 33264 | 1.090 |
2 | 18897 | 1.085 |
Price($) | Vol. | No. |
---|---|---|
1.125 | 43578 | 3 |
1.130 | 87126 | 8 |
1.135 | 1090 | 1 |
1.140 | 141598 | 9 |
1.145 | 64500 | 3 |
Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |